- Bullish trend confirmed on both short and long timeframes
- Highly efficient cash conversion (105% FCF/OCF ratio)
- Trading above its 200-day moving average
LogicBio Therapeutics Inc stock price down 0.213% on Friday
(Updated on Jul 24, 2026)
The LogicBio Therapeutics Inc stock price fell by -0.213% on the last day (Friday, 24th Jul 2026) from $9.37 to $9.35. During the last trading day the stock fluctuated 4.19% from a day low at $9.31 to a day high of $9.70. The price has risen in 5 of the last 10 days and is up by 3.31% over the past 2 weeks. Volume has increased on the last day by 22 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 42 thousand shares were bought and sold for approximately $389.72 thousand.
The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 7.32% during the next 3 months and, with a 90% probability hold a price between $9.51 and $11.19 at the end of this 3-month period.
LOGC Signals & Forecast
The LogicBio Therapeutics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $9.27 and $9.20. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 24, 2026, and so far it has risen 8.47%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. LogicBio Therapeutics Inc gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".
Support, Risk & Stop-loss for LogicBio Therapeutics Inc stock
LogicBio Therapeutics Inc finds support from accumulated volume at $9.15 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.390 between high and low, or 4.19%. For the last week the stock has had daily average volatility of 2.36%.
Our recommended stop-loss: $8.93 (-4.49%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 21 days ago.)
Trading Expectations (LOGC) For The Upcoming Trading Day Of Monday 27th
For the upcoming trading day on Monday, 27th we expect LogicBio Therapeutics Inc to open at $9.45, and during the day (based on 14 day Average True Range), to move between $9.22 and $9.48, which gives a possible trading interval of +/-$0.254 (+/-2.75%) up or down from last closing price. If LogicBio Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 2.75% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $9.36 (0.11%) than the support at $9.15 (2.14%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is LogicBio Therapeutics Inc stock A Buy?
LogicBio Therapeutics Inc holds several positive signals and is within a weak rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
Current score:
5.813
Strong Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on July 27, 2026 - $9.45 ( 1.11%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
LOGC Performance
Trading levels for LOGC
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 9.84 | 5.28% |
| R2 | 9.69 | 3.68% |
| R1 | 9.60 | 2.70% |
| Price | 9.35 | |
| S1 | 9.30 | -0.488% |
| S2 | 9.21 | -1.47% |
| S3 | 9.06 | -3.07% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 9.78 | 4.60% |
| R2 | 9.63 | 2.99% |
| R1 | 9.36 | 0.107% |
| Price | 9.35 | |
| S1 | 9.15 | -2.14% |
| S2 | 9.02 | -3.53% |
| S3 | 8.62 | -7.81% |
FAQ
Click here for our free guide on how to buy LogicBio Therapeutics Inc Stock.
Buy LOGC